Analyst Cory Jubinville, PhD of LifeSci Capital maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report), retaining the price ...

Rocket Pharmaceuticals (RCKT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Gil Blum ...

Lockheed Martin Just Lost a Multibillion-Dollar Deal -- but All Hope Is Not Lost was originally published by The Motley Fool ...

The Nintendo Switch's library is vast and constantly growing. Here is every major new Switch game releasing in 2024 or beyond ...

Fox Army Health Center celebrated the 134th birthday of the facility’s namesake who organized medical services for 60,000 ...